Olfr351 Inhibitors
A variety of chemical compounds act as inhibitors to Olfr351 by modulating this receptor's activity through different biochemical pathways. Some of these chemicals hinder protein synthesis, leading to a reduced presence of Olfr351, while others, acting as agonists for unrelated receptors, may initiate cellular changes that cause the downregulation or desensitization of Olfr351. Additionally, compounds that block sodium channels could dampen neuronal signaling, potentially diminishing the activity of this olfactory receptor. There are also substances that affect Olfr351 indirectly by disrupting critical post-translational modifications or by altering other sensory pathways that indirectly influence olfactory receptor functionality. Competitive antagonists are also at play, which occupy the receptor's ligand-binding site and prevent activation by the natural odorant molecules.
The suppression of Olfr351 by these means is instrumental in dissecting the receptor's significance in the sense of smell. Certain chemicals achieve this by direct interference with the receptor's ability to interact with its natural ligands. The repercussions of such inhibition are significant as they touch on various operational facets of the receptor, ranging from the binding of odorant molecules to crucial modifications after protein synthesis. Each inhibiting agent impacts the receptor in a distinct manner, whether through direct competition, receptor desensitization, or the alteration of associated cellular mechanisms that are vital for the proper functioning of Olfr351.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound inhibits protein biosynthesis by interfering with the translocation step in protein synthesis, thus potentially reducing the protein levels of Olfr351 by preventing its assembly in the endoplasmic reticulum. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
This molecule activates the TRPV1 receptor, which can lead to desensitization of sensory neurons and subsequent downregulation of various receptors, including potential downregulation of Olfr351 due to cellular response to overstimulation. | ||||||
N-Phenylthiourea | 103-85-5 | sc-236086 | 100 g | $319.00 | ||
PTU is known to bind to and inhibit certain chemosensory receptors; it could inhibit Olfr351 by acting as an antagonist, blocking the receptor's active site and preventing its normal ligand interaction. | ||||||
(±)-Menthol | 89-78-1 | sc-250299 sc-250299A | 100 g 250 g | $39.00 $68.00 | ||
Menthol is an agonist of TRPM8 and can indirectly downregulate the function of other GPCRs by triggering counter-regulatory processes within cells expressing Olfr351, which may include receptor internalization or desensitization. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
As a sodium channel blocker, lidocaine can attenuate the activity of neurons, potentially leading to decreased neuronal signaling and a consequent reduction in Olfr351 receptor activity due to reduced cellular excitability. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can affect the glycosylation process in cells. Since glycosylation is important for the proper functioning of GPCRs, this compound could impair the function of Olfr351 by affecting its post-translational modification. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Quinine acts as a flavorant that can influence taste perception and potentially alter the expression or function of taste receptors, which might extend to an inhibitory effect on Olfr351 through modulation of sensory receptor pathways. | ||||||
Cinnamic Aldehyde | 104-55-2 | sc-294033 sc-294033A | 100 g 500 g | $104.00 $228.00 | ||
This aldehyde is also an odorant and could inhibit Olfr351 by binding to the receptor binding site, blocking the interaction with the activating ligand and thus inhibiting receptor activation. | ||||||
Eugenol | 97-53-0 | sc-203043 sc-203043A sc-203043B | 1 g 100 g 500 g | $32.00 $62.00 $218.00 | 2 | |
Eugenol, a compound found in clove oil, could inhibit Olfr351 by acting as a competitive antagonist at the ligand-binding site, thus reducing the receptor's ability to respond to its natural ligand. | ||||||
Isopentyl acetate | 123-92-2 | sc-250190 sc-250190A | 100 ml 500 ml | $107.00 $225.00 | ||
This ester, commonly known as banana oil, may inhibit Olfr351 by binding to the receptor and acting as an antagonist, preventing activation by the natural ligand. | ||||||